Q-VD-OPh, a pancaspase inhibitor, reduces trauma-induced apoptosis and improves the recovery of hind-limb function in rats after spinal cord injury

Neurocirugia

Volumn 20, Issue 6, 2009, Pages 533-540

  Çolak, Ahmet ^a   Antar, V ^b   Karaoglan A ^a   Akdemir, O ^b   Sahan, E ^b   Celik O ^c   Sagmanligil A ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL KULTUR UNIVERSITY   (Turkey)

Author keywords

Caspase; Q VD OPh; SCI; Secondary damage; Spinal cord injury; TUNEL

Indexed keywords

CASPASE INHIBITOR; DNA NUCLEOTIDYLEXOTRANSFERASE; NEUROPROTECTIVE AGENT; Q VD OPH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLEEDING; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; EDEMA; FUNCTIONAL STATUS; HISTOPATHOLOGY; MALE; MICROSCOPY; NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PERFORMANCE; RAT; RATING SCALE; SHAM PROCEDURE; SPINAL CORD INJURY; THROMBUS;

EID: 76749113823     PISSN: 11301473     EISSN: None     Source Type: Journal    
DOI: 10.4321/s1130-14732009000600002     Document Type: Article

References (40)

1. Allen, A.R.: Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J Nerv Ment Dis 1914; 41: 141-147.
2. Barut, S., Unlu, Y.A., Karaoglan, A., et al.: The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg Neurol 2005; 64: 213-220.
3. Bresnahan, J.C., Shuman, S.L., Beattie, M.S.: Evidence for apoptosis of oligodendroglia in long tracts undergoing wallerian degeneration after spinal cord injury (SCI) in monkeys. Soc Abstr Neurosci 1996; 22: 1185.
4. Casha, S., Yu, W.R., Fehlings, M.G.: Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001; 103: 203-218.
5. Caserta, T.M., Smith, A.N., Gultice, A.D., et al.: Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003; 8: 345-352.
6. Colak, A., Karaoglan, A., Barut, S., et al.: Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2005; 2: 327-334.
7. Crowe, M.J., Bresnahan, J.C., Shuman, S.L., et al.: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
8. Deveraux, Q.L., Stennicke, H.R., Salvesen, G.S., Reed, J.C.: Endogenous inhibitors of caspases. J Clin Immunol. 1999; 19: 388-398.
9. Ekert, P.G., Silke, J., Vaux, D.L.: Caspase inhibitors. Cell Death Differ 1999; 6: 1081-1086.
10. Emery, E., Aldana, P., Bunge, M.B., et al.: Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998; 89: 911-920.
11. Gavrieli, Y., Sherman, Y., Ben-Sasson, S.A.: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
12. Ghanem, M.M., Battelli, L.A., Mercer, R.R., et al.: Apoptosis and Bax expression are increased by coal dust in the polycyclic aromatic hydrocarbon-exposed lung. Environ Health Perspect 2006; 114: 1367-1373.
13. Kato, H., Kanellopoulos, G.K., Matsuo, S., et al.: Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Exp Neurol 1997; 148: 464-474.
14. Keane, R.W., Kraydieh, S., Lotocki, G., et al: Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 2001; 60: 422-429.
15. Kerr, J.F., Wyllie, A.H., Currie, A.R.: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
16. Li, H., Colbourne, F., Sun, P., et al.: Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 2000; 31: 176-182.
17. Li, M., Ona, V.O., Chen, M., et al.: Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience 2000; 99: 333-342.
18. Liu, X.Z., Xu, X.M., Hu, R., et al.: Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17: 5395-5406.
19. Lou, J., Lenke, L.G., Ludwig, F.J., O'Brien, M.F.: Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 1998; 36: 683-690.
20. Lu, J., Ashwell, K.W., Waite, P.: Advances in secondary spinal cord injury: role of apoptosis. Spine 2000; 25: 1859-1866.
21. Martin, U., Jarasch, N., Nestler, M., et al.: Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3. Apoptosis 2007; 12: 525-533.
22. Nicholson, D.W.: From bench to clinic with apoptosisbased therapeutic agents. Nature 2000; 407: 810-816.
23. Nonner, D., Panickar, K., Barrett, E.F., Barrett, J.N.: Bone morphogenetic proteins and neurotrophins provide complementary protection of septal cholinergic function during phosphatase inhibitor-induced stress. J Neurochem 2004; 91: 77-87.
24. Raff, M.: Cell suicide for beginners. Nature 1998; 396: 119-122.
25. Patil, K., Sharma, S.C.: Broad spectrum caspase inhibitor rescues retinal ganglion cells after ischemia. Neuroreport 2004; 15: 981-984.
26. Renolleau, S., Fau, S., Goyenvalle, C., et al.: Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007; 100: 1062-1071.
27. Rivlin, A.S., Tator, C.H.: Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977; 47: 577-581.
28. Rudel, T.: Caspase inhibitors in prevention of apoptosis. Herz 1999; 24: 236-241.
29. Samali, A., Zhivotovsky, B., Jones, D., et al.: Apoptosis: cell death defined by caspase activation. Cell Death Differ 1999; 6: 495-496.
30. Springer, J.E., Azbill, R.D., Knapp, P.E.: Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 1999; 5: 943-946.
31. Tarlov, I.M.: Spinal Cord Compression: Mechanism of Paralysis and Treatment. Springfield, Ill: Charles C Thomas; 1957
32. Tewari, M., Quan, L.T., O'Rourke, K., et al.: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
33. Thompson, C.B.: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
34. Vera, Y., Rodriguez, S., Castanares, M., et al.: Functional role of caspases in heat-induced testicular germ cell apoptosis. Biol Reprod 2005; 72: 516-522.
35. Villa, P., Kaufmann, S.H., Earnshaw, W.C.: Caspases and caspase inhibitors. Trends Biochem Sci 1997; 22: 388-393.
36. White, M.G., Emery, M., Nonner, D., Barrett, J.N.: Caspase activation contributes to delayed death of heat-stressed striatal neurons. J Neurochem 2003; 87: 958-968.
37. Yang, L., Sugama, S., Mischak, R.P., et al.: A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol Dis 2004; 17: 250-259.
38. Yong, C., Arnold, P.M., Zoubine, M.N., et al.: Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 1998; 15: 459-472.
39. Zheng, X., Chou, P.M., Mirkin, B.L., Rebbaa, A.: Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res 2004; 64: 1773-1780.
40. Zhu, C., Wang, X., Huang, Z., et al.: Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 2007; 14: 775-84.